EA201600672A2 - DRUGS FROM PLANT RAW MATERIALS - Google Patents
DRUGS FROM PLANT RAW MATERIALSInfo
- Publication number
- EA201600672A2 EA201600672A2 EA201600672A EA201600672A EA201600672A2 EA 201600672 A2 EA201600672 A2 EA 201600672A2 EA 201600672 A EA201600672 A EA 201600672A EA 201600672 A EA201600672 A EA 201600672A EA 201600672 A2 EA201600672 A2 EA 201600672A2
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- extract
- celandine
- drugs
- raw materials
- drug
- Prior art date
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к созданию лекарственного препарата из растительного сырья для лечения широкого спектра заболеваний бактериальной, вирусной и грибковой природы, прежде всего в отоларингологии, пульмонологии и фтизиатрии. Лечебный эффект препарата достигается составом действующих компонентов, содержащим экстракт травы чистотела большого, экстракт коры осины обыкновенной, экстракт корня солодки, подсластители и водно-спиртовой раствор. Препарат содержит нетоксичную концентрацию алкалоидов чистотела, исключающую риск случайных отравлений, с содержанием терапевтической дозы в диапазоне 3-10 мл (в зависимости от возраста и веса пациента) и способен влиять на патогенные микроорганизмы.The invention relates to the creation of a medicinal product from plant materials for the treatment of a wide range of diseases of bacterial, viral and fungal nature, primarily in otolaryngology, pulmonology and phthisiology. The therapeutic effect of the drug is achieved by the composition of active ingredients containing an extract of the herb celandine, aspen bark extract, licorice root extract, sweeteners and water-alcohol solution. The drug contains a non-toxic concentration of alkaloids of the celandine, eliminating the risk of accidental poisoning, with a therapeutic dose in the range of 3-10 ml (depending on the age and weight of the patient) and can affect pathogenic microorganisms.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KZ20150922 | 2015-08-03 |
Publications (3)
Publication Number | Publication Date |
---|---|
EA201600672A2 true EA201600672A2 (en) | 2017-02-28 |
EA201600672A3 EA201600672A3 (en) | 2017-04-28 |
EA031498B1 EA031498B1 (en) | 2019-01-31 |
Family
ID=58228628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201600672A EA031498B1 (en) | 2015-08-03 | 2016-08-02 | Medicinal preparation made of vegetable raw material |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA031498B1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2296579C1 (en) * | 2005-09-21 | 2007-04-10 | Общество с ограниченной ответственностью "Биолит" | Agent with hepatoprotective and cholagostic action |
RU2416391C1 (en) * | 2009-09-03 | 2011-04-20 | Общество с ограниченной ответственностью "СПЛАТ-КОСМЕТИКА" | Composition for oral cavity care |
-
2016
- 2016-08-02 EA EA201600672A patent/EA031498B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA031498B1 (en) | 2019-01-31 |
EA201600672A3 (en) | 2017-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ727975A (en) | Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa | |
EA201101518A1 (en) | PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY | |
EA201892834A1 (en) | COMBINED CHEMOTHERAPY | |
Choi et al. | The inhibitory effects of Geranium thunbergii on interferon-γ-and LPS-induced inflammatory responses are mediated by Nrf2 activation | |
Eteraf-Oskouei et al. | Natural honey: a new and potent anti-angiogenic agent in the air-pouch model of inflammation | |
EA201600672A3 (en) | DRUGS FROM PLANT RAW MATERIALS | |
Qin et al. | Effects of Gui Zhi Ma Huang Ge Ban Tang on the TLR7 pathway in influenza virus infected mouse lungs in a cold environment | |
Hong et al. | Anti-oxidant and anti-inflammatory effects of Fraxinus rhynchophylla on lipopolysaccharide (LPS)-induced murine Raw 264.7 cells | |
EA201890789A1 (en) | CONTAINING ZINEOL COMPOSITION FOR THE TREATMENT OF NOSE DISEASES | |
EA201500406A1 (en) | ANTIGELMITIC GATHERING OWNED | |
EA201490478A1 (en) | METHOD OF GETTING DRY EXTRACTS | |
RU2012130196A (en) | METHOD FOR CORRECTION OF SECONDARY IMMUNO DEFICITS IN CALVES | |
EA201600339A1 (en) | MEANS FOR PREVENTION AND TREATMENT OF THE URINARY GENERAL SYSTEM IN MEN ON THE BASIS OF MEDICINAL PLANTS | |
Taran et al. | Study of membranostabilizing actions of herb of bidens tripartite | |
EA201200271A1 (en) | SOLID MEDICAL FORM, OWNED BY NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPOGOPSIC, ANTIHYCHEMICAL ACTIVITY (OPTIONS) | |
UA111802U (en) | ANTI-INFLAMMATION MEDICINE BASED ON NATURAL COMPONENTS | |
Dapaah | Biological activities of hilleria latifolia (lam.) h. walt and laportea ovalifolia (schumach.) chew | |
RU2013114904A (en) | OIL PROTECTIVE COMPOSITION | |
EA201201308A1 (en) | ANTITUBERCULOSOUS MEDICINE BASED ON 4-THIOROIDOIMINOMETYLPYRIDINIUM PERCHLORATE, ITS TREATMENT METHOD AND TREATMENT METHOD | |
Davydenko et al. | A New Concept of Enhancing the Efficacy of Antimicrobial Therapy of Pyo-Inflammatory Diseases in Children | |
EA201892350A1 (en) | PREPARATION FOR INHALATION ON THE BASIS OF ISOGLYCYRRISINIC ACID OR ITS SALT AND ITS APPLICATION IN THE OBTAINING OF MEDICINES FOR TREATING DISEASES OF THE RESPIRATORY SYSTEM | |
EA201500014A1 (en) | MEANS FOR TREATING COCKIDIOSIS IN BIRDS AND ANIMALS | |
CN104208187A (en) | Preparation method of hair-growing solution | |
Hu Rong et al. | In vitro inhibition of Polygonum cillinerve polysaccharide on Swine transmissible gastroenteritis virus (TGEV). | |
Oteng Dapaah | Biological Activities Of Hilleria Latifolia (Lam.) H. Walt And Laportea Ovalifolia (Schumach.) Chew |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KG TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): KZ RU |